These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 12534765)

  • 1. Adverse drug event monitoring at the Food and Drug Administration.
    Ahmad SR
    J Gen Intern Med; 2003 Jan; 18(1):57-60. PubMed ID: 12534765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.
    Wysowski DK; Swartz L
    Arch Intern Med; 2005 Jun; 165(12):1363-9. PubMed ID: 15983284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of databases in drug postmarketing surveillance.
    Rodriguez EM; Staffa JA; Graham DJ
    Pharmacoepidemiol Drug Saf; 2001; 10(5):407-10. PubMed ID: 11802586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approval of Cancer Drugs With Uncertain Therapeutic Value: A Comparison of Regulatory Decisions in Europe and the United States.
    Salcher-Konrad M; Naci H; Davis C
    Milbank Q; 2020 Dec; 98(4):1219-1256. PubMed ID: 33021339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality assessment of spontaneous triggered adverse event reports received by the Food and Drug Administration.
    Brajovic S; Piazza-Hepp T; Swartz L; Dal Pan G
    Pharmacoepidemiol Drug Saf; 2012 Jun; 21(6):565-70; discussion 571-2. PubMed ID: 22359404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Weber effect and the United States Food and Drug Administration's Adverse Event Reporting System (FAERS): analysis of sixty-two drugs approved from 2006 to 2010.
    Hoffman KB; Dimbil M; Erdman CB; Tatonetti NP; Overstreet BM
    Drug Saf; 2014 Apr; 37(4):283-94. PubMed ID: 24643967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database.
    Szarfman A; Machado SG; O'Neill RT
    Drug Saf; 2002; 25(6):381-92. PubMed ID: 12071774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Announcement: Implementation of the Vaccine Adverse Event Reporting System 2.0 Reporting Form.
    MMWR Morb Mortal Wkly Rep; 2017 Jul; 66(27):738. PubMed ID: 28704349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel adverse events of bevacizumab in the US FDA adverse event reporting system database: a disproportionality analysis.
    Shamloo BK; Chhabra P; Freedman AN; Potosky A; Malin J; Weiss Smith S
    Drug Saf; 2012 Jun; 35(6):507-18. PubMed ID: 22612854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serious Adverse Drug Events Reported to the FDA: Analysis of the FDA Adverse Event Reporting System 2006-2014 Database.
    Sonawane KB; Cheng N; Hansen RA
    J Manag Care Spec Pharm; 2018 Jul; 24(7):682-690. PubMed ID: 29952714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical bovine thrombin: a 21-year review of topical bovine thrombin spontaneous case safety reports submitted to FDA's Adverse Event Reporting System.
    Clark JA; Humphries JE; Crean S; Reynolds MW
    Pharmacoepidemiol Drug Saf; 2010 Feb; 19(2):107-14. PubMed ID: 20014051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse drug events and the Freedom of Information Act: an apple in Eden.
    Stang PE; Fox JL
    Ann Pharmacother; 1992 Feb; 26(2):238-43. PubMed ID: 1554939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDA Adverse Event Reporting System: Recruiting Doctors to Make Surveillance a Little Less Passive.
    Mann JM
    Food Drug Law J; 2015; 70(3):371-94, i. PubMed ID: 26630821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The FDA and drug safety: a proposal for sweeping changes.
    Furberg CD; Levin AA; Gross PA; Shapiro RS; Strom BL
    Arch Intern Med; 2006 Oct; 166(18):1938-42. PubMed ID: 17030825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulated reporting: the impact of US food and drug administration-issued alerts on the adverse event reporting system (FAERS).
    Hoffman KB; Demakas AR; Dimbil M; Tatonetti NP; Erdman CB
    Drug Saf; 2014 Nov; 37(11):971-80. PubMed ID: 25255848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
    MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the evidence consistency of pharmacovigilance outcomes between Food and Drug Administration Adverse Event Reporting System and electronic medical record data for acute mania patients.
    Duan R; Zhang X; Du J; Huang J; Tao C; Chen Y
    Health Informatics J; 2020 Jun; 26(2):753-764. PubMed ID: 30887861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Likelihood ratio test-based method for signal detection in drug classes using FDA's AERS database.
    Huang L; Zalkikar J; Tiwari RC
    J Biopharm Stat; 2013; 23(1):178-200. PubMed ID: 23331230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse Event Reports Associated with Vaginal Mesh: An Interrupted Time Series Analysis.
    Leiter V; White SK; Walters A
    Womens Health Issues; 2017; 27(3):279-285. PubMed ID: 28233636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Narrative Review: The FDA's Perfunctory Approach of Dietary Supplement Regulations Giving Rise to Copious Reports of Adverse Events.
    Li W; Wertheimer A
    Innov Pharm; 2023; 14(1):. PubMed ID: 38035313
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.